Research & Development
ProTom awarded FDA 510(k) clearance for Radiance 330 single room proton therapy system
8 October 2019 -

Proton therapy technology company ProTom International Holding Corporation reported on Monday the receipt of the 510(k) clearance from the US Food and Drug Administration (FDA) for its Radiance 330 proton therapy system.

Installed at Massachusetts General Hospital (MGH) in Boston, Massachusetts, the company's Radiance 330 proton therapy system is a compact, single room system equipped with an advanced pencil beam scanning system and integrated imaging and control system.

By using the advanced pencil beam scanning technology, modular designed treatment system and the compact synchrotron particle accelerator, the company's Radiance 330 is a smaller, lighter and cleaner system. The Radiance 330 compact synchrotron can be installed within an interior accelerator vault space of 20′ x 30′ and requires up to 40% less radiation shielding.

Mass General Hospital is the original and the largest teaching hospital of Harvard Medical School located in Boston, Massachusetts.

Login
Username:

Password: